Life Science Daily News launched in November 2025 with a simple premise: that researchers, biotech founders, healthcare professionals, communications specialists and industry professionals should be able to publish their own work directly to a specialist audience,...
The impact of climate change is usually discussed in terms of heatwaves and floods. While less visible, its impact on infectious diseases is equally consequential for public health. New data from the UK Health Security Agency (UKHSA) showing a surge in chikungunya...
Life science news 13 July 2026: Vertex seals a $10 billion deal for rare endocrine specialist Crinetics, the FDA clears the first dual BAFF/APRIL inhibitor for IgA nephropathy, and Novartis acquires a UK cancer therapy spinout in a blockbuster week for pharma, biotech...
The current news cycle is dominated by new and exotic-sounding organisms and chemicals: PFOS, bisphenols, phthalates, Mpox, New World screwworm, Andes hantavirus, Ebola bundibugyo, Borrelia burgdorferi, dengue, and chikungunya. What do they have in common? They are...
Life science news 6 July 2026: the FDA expands the world’s first CRISPR gene therapy to children as young as two, Ipsen commits up to $1.75 billion for a late-stage blood cancer drug, and two first-in-class FDA approvals reshape the cell therapy landscape in a busy...
Last year it was Joe Biden and Barnaby Joyce who made public their diagnoses of prostate cancer. Before them, came other household names battling this condition – from Ben Stiller to Rod Stewart. This admission, on Jeremy Clarkson’s own TV show for his need of...
Most diseases do not begin the day a diagnosis is made. The body often goes through a series of changes long before medicine has a name for what is happening, and the period between apparent health and confirmed disease is something we still don't fully understand.¹...
Life science news 1 June 2026: FDA approvals, a landmark obesity pill advance and a $10.5 billion Pfizer partnership define a milestone week for pharma and biotech. The week of 24 to 30 May 2026 delivered a string of significant regulatory milestones, high-value...
Burnout has long been viewed as a matter of individual resilience. Individuals are advised to meditate, sleep well, optimise morning routines, cut down on screen time, show gratitude, achieve a good work-life balance, or just be better at managing time. While these...
Life science news 25 May 2026: Lilly's retatrutide delivers bariatric-surgery-level weight loss in Phase 3, two landmark FDA approvals reshape oncology and hepatology, and a UK biotech targets the global AMR crisis. The week of 17 to 24 May 2026 delivered a dense...
The healthcare sector has a burnout problem it keeps trying to solve with the wrong tools. Across Australia and globally, rates of psychological distress, absenteeism and early career exit among healthcare workers have reached levels that can no longer be attributed...
Across the life sciences sector, a quiet crisis is unfolding. Researchers, clinicians, nurses, and social workers describe feeling trapped in a cycle with no exit: outwardly productive, inwardly depleted. Burnout is not a new phenomenon, but the life sciences...
Life science news 18 May 2026: FDA leadership turmoil, a landmark Alzheimer's breakthrough and a $15 billion China licensing deal define a historic week for the global industry. The week of 10 to 17 May 2026 delivered a concentration of high-impact events across...
Life science news 11 May 2026: M&A momentum, artificial intelligence diagnostics and a record week for deal-making define an active seven days for the global life science industry. The week of 4 to 10 May 2026 produced a dense cluster of major acquisitions, a...
GSK has entered into an exclusive licensing agreement with Chinese biotech Suzhou Siran Biotechnology (SiranBio), securing global rights to the company's early-stage small interfering RNA (siRNA) therapy, SA030, in a deal worth up to $1.005 billion in potential...
For the life sciences sector, the global nursing shortage is not a background public health concern. It is a clinical trial staffing problem, a pharmaceutical market access problem, and a real-world evidence problem. The WHO's 2025 State of the World's Nursing report...
Life science news 4 May 2026: Eli Lilly's record $19.8 billion quarterly earnings, the FDA's real-time clinical trial revolution and a landmark week for UK regulatory reform define a momentous seven days for global life science. Eli Lilly reported worldwide revenue of...
Precision medicine is no longer a futuristic concept. Genomic panels, pharmacogenomic testing, advanced biomarker analysis, and individualized risk stratification tools are all available today. Yet for the vast majority of patients walking into a primary care office,...